The advertisement promotes NUBEQA® (darolutamide) as an approved treatment for mCSPC and nmCRPC, highlighting important safety information regarding ischemic heart disease associated with the medication.
Creative Information
| CID: | 65958763-5f1a-4f64-b909-2b545f9712b5 |
| CRID: | 82_1075-932977 |
| Domain: | nubeqahcp.com |
| Seat: | PP |
| Size: | 300x600 |
| Bid: | $0.70 |
| Timestamp: | 11/20/2025, 4:39:51 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/20/2025, 5:39:18 PM | 9.17s | |
| adomain_analysis | success | 11/20/2025, 6:32:17 PM | 3.51s | |
| adomain_capture | success | 11/20/2025, 6:32:14 PM | 0.12s | |
| ad_render | success | 11/20/2025, 5:39:09 PM | 25.15s | |
| brand_mapping | success | 11/20/2025, 6:32:18 PM | 3.63s | |
Analysis Results
Ad Format: banner
Brands: NUBEQA
Sensitive:Misleading Health ClaimsUnverified Medical TreatmentsPharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x600 | ||||||||||||||||||||||
| Data Transferred: | 1326.46 KB | ||||||||||||||||||||||
| Render Time: | 9.50 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1326.70 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain
Ad Preview
Landing Page
Creatives
